Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
7,624 results
- ARTSS-2Independent statistical analysis of Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- AS900672-Enriched in Ovulation Induction: Complete Statistical AnalysisIndependent statistical analysis of AS900672-Enriched in Ovulation Induction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553514).
- ASCENDIndependent statistical analysis of Assessing Symptomatic Clinical Episodes in Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03595579).
- AscenD-LBIndependent statistical analysis of Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ASCEND-PIndependent statistical analysis of Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I: Complete Statistical AnalysisIndependent statistical analysis of Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I: primary endpoint results, effect estimate with confidence interval, sample-size…
- Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II: Complete Statistical AnalysisIndependent statistical analysis of Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II: primary endpoint results, effect estimate with confidence interval, sample-size…
- Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients: Complete Statistical AnalysisIndependent statistical analysis of Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients: Complete Statistical AnalysisIndependent statistical analysis of Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ASCENTIndependent statistical analysis of A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ASCENTIndependent statistical analysis of Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ASCLEPIOS IIndependent statistical analysis of Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ASDIndependent statistical analysis of Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ASIA MRI ICDIndependent statistical analysis of A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ASPIREIndependent statistical analysis of Coaching Veterans to Healthy Weights and Wellness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00967668).
- ASPIREIndependent statistical analysis of Family-Focused, Stress-Reduction Program to Improve the Health Care of Urban Children With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ASPIRINIndependent statistical analysis of Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02409680).
- Aspirin and Enoxaparin for VTE in Trauma: Complete Statistical AnalysisIndependent statistical analysis of Aspirin and Enoxaparin for VTE in Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02396732).
- Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers: Complete Statistical AnalysisIndependent statistical analysis of Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Aspirin for Treatment of Multiple Sclerosis-Related Fatigue: Complete Statistical AnalysisIndependent statistical analysis of Aspirin for Treatment of Multiple Sclerosis-Related Fatigue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00467584).
- Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation: Complete Statistical AnalysisIndependent statistical analysis of Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ASSENTIndependent statistical analysis of Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals’ Pandemic Influenza Vaccine (GSK1562902A) in Adults: Complete Statistical AnalysisIndependent statistical analysis of Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule: Complete Statistical AnalysisIndependent statistical analysis of Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule: primary endpoint results, effect estimate with confidence interval, sample-size…
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer: Complete Statistical AnalysisIndependent statistical analysis of Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.: Complete Statistical AnalysisIndependent statistical analysis of Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo: Complete Statistical AnalysisIndependent statistical analysis of Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Assessing and Improving Patient Knowledge About Keloid Scars (Keloids): Complete Statistical AnalysisIndependent statistical analysis of Assessing and Improving Patient Knowledge About Keloid Scars (Keloids): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01176877).
- Assessing Neuroinflammation in GWI Using MRS: Complete Statistical AnalysisIndependent statistical analysis of Assessing Neuroinflammation in GWI Using MRS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04638998).
- Assessing PA-824 for Tuberculosis (the APT Trial): Complete Statistical AnalysisIndependent statistical analysis of Assessing PA-824 for Tuberculosis (the APT Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02256696).
- Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI: Complete Statistical AnalysisIndependent statistical analysis of Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03367312).
- Assessing Supported Employment With Veterans With Felony Convictions and Mental Illness or Substance Abuse: Complete Statistical AnalysisIndependent statistical analysis of Assessing Supported Employment With Veterans With Felony Convictions and Mental Illness or Substance Abuse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Assessing the Effect of a Blood-based Colorectal Cancer Screening Test on Screening Adherence and Colonoscopy Completion: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Effect of a Blood-based Colorectal Cancer Screening Test on Screening Adherence and Colonoscopy Completion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America:…
- Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size…
- Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101): Complete Statistical AnalysisIndependent statistical analysis of Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia: Complete Statistical AnalysisIndependent statistical analysis of Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Assessment of a New “Boosting” Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Assessment of a New "Boosting" Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Assessment of Alcon’s Ocular Image Quantification System: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Alcon's Ocular Image Quantification System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01282138).
- Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Assessment of Cough Reflex in Lung Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Cough Reflex in Lung Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00584077).
- Assessment of Dystussia in Traumatic Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Dystussia in Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02240329).
- Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Assessment of KAN-101 in Celiac Disease (ACeD): Complete Statistical AnalysisIndependent statistical analysis of Assessment of KAN-101 in Celiac Disease (ACeD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04248855).